EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 23 April 2026

The escalating burden of non-communicable diseases demands new solutions

Read the full report here.

Managing the status quo is not an option – it is time to change how we fund and deliver health in Europe.

Non-communicable diseases (NCDs) like heart disease, diabetes, obesity and Alzheimer’s, account for 88-90% of all deaths in Europe, and almost one in three people over fifty are living with two or more chronic conditions. They place a heavy cost on European societies in terms of expensive hospital and long-term care, reduced labour force participation, and sickness and disability benefits.

Five major NCDs are estimated to cost EU countries €530 billion annually, which is more than 3% of the EU’s combined annual GDP. And this is not even accounting for the “invisible” burden of informal care, which for Alzheimer’s alone was estimated to over $200 billion for the European region in 2019.

World IP Day 2026: keeping Europe on track for innovation
23 April 2026

As Europe strives to compete globally in life sciences, predictable and robust IP incentives will determine whether... Read more

The €240 billion leak: Why Europe’s health resilience starts with integrated obesity, diabetes...
22 April 2026

Europe is treating the symptoms of a crisis while ignoring the drivers behind it. By the time an EU citizen is diagnosed... Read more

Get ready for IHI Call 13 – launching this summer

The Innovative Health Initiative (IHI) is preparing its next call for proposals, and it brings new opportunities for collaboration across Europe’s health ecosystem. We encourage all interested stakeholders to explore the upcoming topics and start building strong consortia ahead of the official launch in the Summer.

What’s coming in Call 13?

IHI European HealthCare Incubator Network
New Approach Methodologies (NAMs)
Ageing & immune system

Learn more here.

Events

Towards comprehensive cardiovascular health checks across Europe
07 May 2026 (Brussels, Belgium)

Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity in Europe, despite significant advances... Read more

European Pharmaceutical Law Forum
19 May 2026 (Brussels, Belgium)

The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical... Read more

What we are reading

International 3Rs Prize
On 22 April 2026 (NC3Rs)

An annual Prize awarded for a paper that describes outstanding and original work that has or could have major impacts... Read more

Health Checks for Cardiovascular diseases
On 21 April 2026 (European Commission)

The proposed Council recommendation on health checks for cardiovascular diseases will support Member States in organising... Read more

#AlwaysInnovating: There’s more to medicines and vaccines
On 21 April 2026 (IFPMA)

Investing in innovative medicines and vaccines doesn’t just save lives – it transforms... Read more

Health, resilience and prosperity: Why immunization matters
On 20 April 2026 (POLITICO)

To strengthen Europe’s resilience and health security, a policy shift is needed: recognize immunization... Read more

Healthcare needs judgement, not just metrics
On 08 April 2026 (University of St Andrews)

Dr Sandra Romenska reflected on why healthcare leaders can end up focusing on what is easiest to count rather than... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu